68.31.Z - Real estate brokerage
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
52.10.B - Warehousing and storage of other goods
68.20.Z - Rental and management of own or leased real estate
70.22.Z - Head office activities and management consultancy
73.20.Z - Market research and public opinion polling
82.99.Z - Other business support activities, not elsewhere classified
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,1 | -0 | 0 | 127,8 |
Gross profit (loss) | -0,1 | -0,1 | -0 | 98,7 |
EBITDA | -0,1 | -0 | 0 | 130,2 |
Short time liabilities | 0,1 | 0,2 | 0,2 | 11,5 |
Other operating costs | 0 | 0 | 0 | 13,3 |
Equity capital | -0,1 | -0,2 | -0,2 | -0,5 |
Operating profit (EBIT) | -0,1 | -0 | 0 | 127,9 |
Assets | 0 | 0 | 0 | 100,8 |
Net profit (loss) | -0,1 | -0,1 | -0 | 98,7 |
Cash | 0 | 0 | 0 | -80,7 |
Liabilities and provisions for liabilities | 0,1 | 0,2 | 0,2 | 11,5 |
Net income from sale | 0 | 0,1 | 0,1 | 46 |
Working assets | 0 | 0 | 0 | 115,7 |
Other income costs | 0 | 0 | 0 | 501 |
Depreciation | 0 | 0 | 0 | -15,3 |
% | % | % | p.p. | |
Profitability of capital | 123,5 | 35,8 | 0,5 | -35,3 |
Equity capital to total assets | -576,7 | -810,4 | -405,5 | 404,9 |
Gross profit margin | -1249,3 | -81,7 | -0,7 | 81 |
EBITDA Margin | -1221,8 | -65,9 | 13,7 | 79,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 4333 | 936 | 715 | -221 |
Current financial liquidity indicator | 0.13492721319198608 | 0.09961628913879395 | 0.19269369542598724 | 0,1 |
Net dept to EBITDA | -0.7716633081436157 | -3.5153238773345947 | 12.743301391601562 | 16,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane